The APAC sepsis diagnostics market is expected to grow from US$ 131.79 million in 2021 to US$ 249.70 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028.

The rising need for rapid diagnostics for sepsis fueled the research activities among key players in recent years. Both the existing players and the start-ups in sepsis diagnostics are well supported financially by government and research organizations. For instance, in April 2020, Cytovale Inc. announced its partnership with the Biomedical Advanced Research and Development Authority (BARDA) for sepsis diagnosis in patients with respiratory infections, including COVID-19. The research was estimated to stand at US$ 5.9 million, with a contribution of approximately US$ 3.83 million by BARDA. Additionally, in an endeavor to shape the future of sepsis research, the National Institute of General Medical Sciences (NIGMS) intends to use the NIH SBIR/STTR program to support preclinical and clinical sepsis studies to develop improved diagnostic tools and therapies. Diagnostics companies are continuously securing funding to establish rapid sepsis diagnostic tests.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC sepsis diagnostics market. The APAC sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.

APAC Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million )

APAC Sepsis Diagnostics Market Segmentation

The APAC sepsis diagnostics market is segmented based on product, technology, method, test type, pathogen, end user, and country. Based on product, the APAC sepsis diagnostics market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media dominated the APAC sepsis diagnostics market in 2021. Based on technology, the APAC sepsis diagnostics market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment dominated the APAC sepsis diagnostics market in 2021. Based on method, the APAC sepsis diagnostics market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment dominated the APAC sepsis diagnostics market in 2021. Based on test type, the APAC sepsis diagnostics market is categorized into point-of-care tests and laboratory tests. The laboratory tests segment dominated the APAC sepsis diagnostics market in 2021. Based on pathogen, the APAC sepsis diagnostics market is categorized into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment dominated the APAC sepsis diagnostics market in 2021. Based on end user, the APAC sepsis diagnostics market is categorized into hospitals, pathology and reference laboratories, and others. The hospitals segment dominated the APAC sepsis diagnostics market in 2021. Based on country, the APAC sepsis diagnostics market is segmented into Australia, China, India, Japan, South Korea, and the Rest of APAC. China dominated the APAC sepsis diagnostics market in 2021.

Key players operating in the APAC sepsis diagnostics market include Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; and T2 Biosystems, Inc. by Altair.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1   APAC Sepsis Diagnostics Market – By Product
1.3.2   APAC Sepsis Diagnostics Market – By Technology
1.3.3   APAC Sepsis Diagnostics Market – By Method
1.3.4   APAC Sepsis Diagnostics Market – By Test Type
1.3.5   APAC Sepsis Diagnostics Market – By Pathogen
1.3.6   APAC Sepsis Diagnostics Market – By End User
1.3.7   APAC Sepsis Diagnostics Market – By Country
2. Key Takeaways
3.   Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Sepsis Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1   APAC PEST Analysis
4.3 Experts Opinion
5. APAC Sepsis Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1   High Frequency of Sepsis due to Increasing Nosocomial Infections
5.1.2   Expansion in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1   Loss of Skilled Professionals
5.3 Market Opportunities
5.3.1   Development in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1   Increasing Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. Sepsis Diagnostics Market– APAC Analysis
6.1 APAC Sepsis Diagnostics Market Revenue Forecast and Analysis
7. APAC Sepsis Diagnostics Market – By Product
7.1 Overview
7.2 APAC Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1   Overview
7.3.2   Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1   Overview
7.4.2   Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1   Overview
7.5.2   Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1   Overview
7.6.2   Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. APAC Sepsis Diagnostics Market – By Technology
8.1 Overview
8.2 APAC Sepsis Diagnostics Market Share by Technology – 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1   Overview
8.3.2   Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1   Polymerase Chain Reaction
8.3.2.1.1   Overview
8.3.2.1.2   Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2   Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1   Overview
8.3.2.2.2   Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3   Syndromic Panel-Based Testing
8.3.2.3.1   Overview
8.3.2.3.2   Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4   Microarrays
8.3.2.4.1   Overview
8.3.2.4.2   Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1   Overview
8.4.2   Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1   Overview
8.5.2   Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1   Overview
8.6.2   Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1   Overview
8.7.2   Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1   Overview
8.8.2   Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Sepsis Diagnostics Market – By Method
9.1 Overview
9.2 APAC Sepsis Diagnostics Market Share by Method – 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1   Overview
9.3.2   Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1   Overview
9.4.2   Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.   APAC Sepsis Diagnostics Market – By Test Type
10.1   Overview
10.2   APAC Sepsis Diagnostics Market Share by Test Type – 2021 & 2028 (%)
10.3   Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4   Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.   APAC Sepsis Diagnostics Market – By Pathogen
11.1   Overview
11.2   APAC Sepsis Diagnostics Market Share by Pathogen – 2021 & 2028 (%)
11.3   Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4   Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5   Others
11.5.1 Overview
11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.   APAC Sepsis Diagnostics Market – By End User
12.1   Overview
12.2   APAC Sepsis Diagnostics Market Share by End User – 2021 & 2028 (%)
12.3   Hospitals
12.3.1 Overview
12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4   Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5   Others
12.5.1 Overview
12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13.   APAC Sepsis Diagnostics Market – By Country Analysis
13.1   Asia Pacific: Sepsis Diagnostics Market
13.1.1 Overview
13.1.2 APAC: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
13.1.2.1 China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.1.1 China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.1.2 China: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)
13.1.2.1.3 China: Sepsis Diagnostics Market, by Technology, 2019–2028 (USD Million)
13.1.2.1.3.1 China Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
13.1.2.1.4 China: Sepsis Diagnostics Market, by Method, 2019–2028 (USD Million)
13.1.2.1.5 China: Sepsis Diagnostics Market, by Test Type, 2019–2028 (USD Million)
13.1.2.1.6 China: Sepsis Diagnostics Market, by Pathogen, 2019–2028 (USD Million)
13.1.2.1.7 China: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)
13.1.2.2 Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.2.1 Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.2.2 Japan: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)
13.1.2.2.3 Japan: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)
13.1.2.2.3.1 Japan Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
13.1.2.2.4 Japan: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)
13.1.2.2.5 Japan: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)
13.1.2.2.6 Japan: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)
13.1.2.2.7 Japan: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)
13.1.2.3 India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.3.1 India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.3.2 India: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)
13.1.2.3.3 India: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)
13.1.2.3.3.1 India Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
13.1.2.3.4 India: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)
13.1.2.3.5 India: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)
13.1.2.3.6 India: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)
13.1.2.3.7 India: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)
13.1.2.4 Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.4.1 Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.4.2 Australia: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)
13.1.2.4.3 Australia: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)
13.1.2.4.3.1 Australia Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
13.1.2.4.4 Australia: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)
13.1.2.4.5 Australia: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)
13.1.2.4.6 Australia: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)
13.1.2.4.7 Australia: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)
13.1.2.5 South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.5.1 South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.5.2 South Korea: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)
13.1.2.5.3 South Korea: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)
13.1.2.5.3.1 South Korea Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
13.1.2.5.4 South Korea: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)
13.1.2.5.5 South Korea: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)
13.1.2.5.6 South Korea: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)
13.1.2.5.7 South Korea: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)
13.1.2.6 Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.6.1 Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.6.2 Rest of Asia Pacific: Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)
13.1.2.6.3 Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)
13.1.2.6.3.1 Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
13.1.2.6.4 Rest of Asia Pacific: Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)
13.1.2.6.5 Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)
13.1.2.6.6 Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)
13.1.2.6.7 Rest of Asia Pacific: Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)
14.   Sepsis Diagnostics Market–Industry Landscape
14.1   Overview
14.2   Growth Strategies in the Sepsis Diagnostics Market (%)
14.3   Organic Developments
14.3.1 Overview
14.4   Inorganic Developments
14.4.1 Overview
15.   Company Profiles
15.1   Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2   F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3   Immunexpress Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4   BD
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5   Danaher (Beckman Coulter)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6   Luminex Corporation
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7   THERMO FISHER SCIENTIFIC INC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8   bioMerieux SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9   T2 Biosystems, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16.   Appendix
16.1   About The Insight Partners
16.2   Glossary of Terms

LIST OF TABLES
Table 1. China: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 2. China: Sepsis Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)
Table 3. China: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and forecast to 2028 (USD Million)
Table 4. China: Sepsis Diagnostics Market, by Method– Revenue and forecast to 2028 (USD Million)
Table 5. China: Sepsis Diagnostics Market, by Test Type– Revenue and forecast to 2028 (USD Million)
Table 6. China: Sepsis Diagnostics Market, by Pathogen – Revenue and forecast to 2028 (USD Million)
Table 7. China: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 9. Japan: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 10.   Japan: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
Table 11.   Japan: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)
Table 12.   Japan: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)
Table 13.   Japan: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)
Table 14.   Japan: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)
Table 15.   India: Sepsis Diagnostics Market, By Product– Revenue and Forecast to 2028(USD Million)
Table 16.   India: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 17.   India: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
Table 18.   India: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)
Table 19.   India: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)
Table 20.   India: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)
Table 21.   India: Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)
Table 22.   Australia: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 23.   Australia: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 24.   Australia: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
Table 25.   Australia: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)
Table 26.   Australia: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)
Table 27.   Australia: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)
Table 28.   Australia: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 29.   South Korea: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 30.   South Korea: Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 31.   South Korea: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
Table 32.   South Korea: Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)
Table 33.   South Korea: Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)
Table 34.   South Korea: Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)
Table 35.   South Korea: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 36.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 37.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology– Revenue and Forecast to 2028 (USD Million)
Table 38.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)
Table 39.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Method– Revenue and Forecast to 2028 (USD Million)
Table 40.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type– Revenue and Forecast to 2028 (USD Million)
Table 41.   Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen– Revenue and Forecast to 2028 (USD Million)
Table 42.   Rest of Asia Pacific: Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 43.   Organic Developments in the Sepsis Diagnostics Market
Table 44.   Inorganic Developments in the Sepsis Diagnostics Market
Table 45.   Glossary of Terms

LIST OF FIGURES
Figure 1. APAC Sepsis Diagnostics Market Segmentation
Figure 2. APAC Sepsis Diagnostics Market, By Country
Figure 3. APAC Sepsis Diagnostics Market Overview
Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
Figure 5. China is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. APAC: PEST Analysis
Figure 7. APAC Experts Opinion
Figure 8. APAC Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. APAC Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10.   APAC Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11.   APAC Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12.   APAC Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13.   APAC Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14.   APAC Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15.   APAC Sepsis Diagnostics Market Share by Technology – 2021 & 2028 (%)
Figure 16.   APAC Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17.   APAC Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18.   APAC Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19.   APAC Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20.   APAC Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21.   APAC Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22.   APAC Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23.   APAC Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24.   APAC Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25.   APAC Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26.   APAC Sepsis Diagnostics Market Share by Method – 2021 & 2028 (%)
Figure 27.   APAC Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28.   APAC Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29.   APAC Sepsis Diagnostics Market Share by Test Type – 2021 & 2028 (%)
Figure 30.   APAC Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31.   APAC Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32.   APAC Sepsis Diagnostics Market Share by Pathogen – 2021 & 2028 (%)
Figure 33.   APAC Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34.   APAC Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35.   APAC Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36.   APAC Sepsis Diagnostics Market Share by End User – 2021 & 2028 (%)
Figure 37.   APAC Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38.   APAC Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39.   APAC Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40.   Asia Pacific: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 41.   APAC: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 42.   China: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 43.   Japan: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 44.   India: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 45.   Australia: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 46.   South Korea: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 47.   Rest of Asia Pacific: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 48.   Growth Strategies in the Sepsis Diagnostics Market (%)
“

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC sepsis diagnostics market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the APAC sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the APAC sepsis diagnostics market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Asia Pacific Sepsis Diagnostics Market

● Abbott
● F. HOFFMANN-LA ROCHE LTD.
● Immunexpress Inc.
● BD
● Danaher (Beckman Coulter)
● Luminex Corporation
● THERMO FISHER SCIENTIFIC INC.
● bioMerieux SA
● T2 Biosystems, Inc